AP2000002017A0 - Salts of paroxetine. - Google Patents
Salts of paroxetine.Info
- Publication number
- AP2000002017A0 AP2000002017A0 APAP/P/2000/002017A AP2000002017A AP2000002017A0 AP 2000002017 A0 AP2000002017 A0 AP 2000002017A0 AP 2000002017 A AP2000002017 A AP 2000002017A AP 2000002017 A0 AP2000002017 A0 AP 2000002017A0
- Authority
- AP
- ARIPO
- Prior art keywords
- paroxetine
- salts
- therapy
- preparing
- processes
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical class C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
- 229960002296 paroxetine Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003053 piperidines Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Abstract
Piperidine compounds, processes for preparing them, pharmaceutical compositions comprising them and their use in therapy are disclosed.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9814316.7A GB9814316D0 (en) | 1998-07-02 | 1998-07-02 | Novel compounds |
| PCT/EP1999/004543 WO2000001692A1 (en) | 1998-07-02 | 1999-06-30 | Salts of paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2000002017A0 true AP2000002017A0 (en) | 2000-12-31 |
Family
ID=10834803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/2000/002017A AP2000002017A0 (en) | 1998-07-02 | 1999-06-30 | Salts of paroxetine. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1091958A1 (en) |
| JP (1) | JP2002519421A (en) |
| KR (1) | KR20010053337A (en) |
| CN (1) | CN1314906A (en) |
| AP (1) | AP2000002017A0 (en) |
| AU (2) | AU4903999A (en) |
| BG (1) | BG105204A (en) |
| BR (1) | BR9911679A (en) |
| CA (1) | CA2336470A1 (en) |
| CZ (1) | CZ20004923A3 (en) |
| EA (1) | EA200100098A1 (en) |
| GB (1) | GB9814316D0 (en) |
| HU (1) | HUP0103712A3 (en) |
| ID (1) | ID27766A (en) |
| IL (1) | IL140385A0 (en) |
| NO (1) | NO20006547L (en) |
| PL (1) | PL345365A1 (en) |
| SK (1) | SK20242000A3 (en) |
| TR (1) | TR200100055T2 (en) |
| WO (1) | WO2000001692A1 (en) |
| ZA (2) | ZA992899B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1622630B1 (en) | 2003-05-07 | 2012-08-29 | Osteologix A/S | Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions |
| ES2275218T3 (en) | 2003-05-07 | 2007-06-01 | Osteologix A/S | HYDROSOLUBLE STRONTIUM SALTS FOR THE TREATMENT OF CARTILAGOS AND / OR BONE AFFECTIONS. |
| US20080167513A1 (en) | 2004-02-26 | 2008-07-10 | Osteologlx A/S | Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions |
| US7589235B2 (en) | 2004-05-06 | 2009-09-15 | Osteologix, A/S | High yield and rapid synthesis methods for producing metallo-organic salts |
| KR100672184B1 (en) * | 2004-09-21 | 2007-01-19 | 주식회사종근당 | Choline or Choline Derivative Salts of Paroxetine |
| ES2745411T3 (en) | 2006-07-27 | 2020-03-02 | Wang Nai Fang | Arylsulfanil compounds and compositions for administration of active agents |
| CN109212055B (en) * | 2018-08-19 | 2021-05-07 | 丁立平 | Gas chromatography-mass spectrometry combined method for determining four trace monohalogenated phenylacetic acids in drinking water |
| CN109342633B (en) * | 2018-11-27 | 2020-10-02 | 北京市化工职业病防治院 | Method for detecting metabolites of benzene, toluene and xylene in urine |
| CN111337460B (en) * | 2018-12-18 | 2021-09-17 | 中国科学院大连化学物理研究所 | High-stability Halo-tag probe and synthesis and biological application thereof |
| CN116283778B (en) * | 2023-02-23 | 2025-08-29 | 江苏理工学院 | A pyrazole carboxylic acid compound and its preparation method and application |
| US20250091996A1 (en) | 2023-09-15 | 2025-03-20 | King Faisal University | 2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
| EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
| CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
| HU221921B1 (en) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them |
| SK283394B6 (en) * | 1997-06-10 | 2003-07-01 | Synthon B. V. | 4-phenylpiperidine compounds and its pharmaceutically acceptable salts, process for their preparation, medicament containing them and their use |
| SK11812000A3 (en) * | 1998-02-06 | 2001-08-06 | Smithkline Beecham Plc | Salts of paroxetine |
-
1998
- 1998-07-02 GB GBGB9814316.7A patent/GB9814316D0/en not_active Ceased
-
1999
- 1999-04-23 ZA ZA9902899A patent/ZA992899B/en unknown
- 1999-06-30 BR BR9911679-0A patent/BR9911679A/en not_active Application Discontinuation
- 1999-06-30 SK SK2024-2000A patent/SK20242000A3/en unknown
- 1999-06-30 CA CA002336470A patent/CA2336470A1/en not_active Abandoned
- 1999-06-30 PL PL99345365A patent/PL345365A1/en not_active Application Discontinuation
- 1999-06-30 WO PCT/EP1999/004543 patent/WO2000001692A1/en not_active Ceased
- 1999-06-30 AU AU49039/99A patent/AU4903999A/en not_active Abandoned
- 1999-06-30 JP JP2000558095A patent/JP2002519421A/en active Pending
- 1999-06-30 CN CN99810197A patent/CN1314906A/en active Pending
- 1999-06-30 AP APAP/P/2000/002017A patent/AP2000002017A0/en unknown
- 1999-06-30 EP EP99932772A patent/EP1091958A1/en not_active Withdrawn
- 1999-06-30 EA EA200100098A patent/EA200100098A1/en unknown
- 1999-06-30 CZ CZ20004923A patent/CZ20004923A3/en unknown
- 1999-06-30 TR TR2001/00055T patent/TR200100055T2/en unknown
- 1999-06-30 KR KR1020007015100A patent/KR20010053337A/en not_active Withdrawn
- 1999-06-30 HU HU0103712A patent/HUP0103712A3/en unknown
- 1999-06-30 ID IDW20010252A patent/ID27766A/en unknown
- 1999-06-30 IL IL14038599A patent/IL140385A0/en unknown
-
2000
- 2000-12-21 NO NO20006547A patent/NO20006547L/en not_active Application Discontinuation
-
2001
- 2001-01-02 ZA ZA200100020A patent/ZA200100020B/en unknown
- 2001-01-31 BG BG105204A patent/BG105204A/en unknown
- 2001-07-11 AU AU2002100370A patent/AU2002100370A4/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200100020B (en) | 2002-03-25 |
| BG105204A (en) | 2001-11-30 |
| NO20006547D0 (en) | 2000-12-21 |
| KR20010053337A (en) | 2001-06-25 |
| ZA992899B (en) | 2000-03-29 |
| TR200100055T2 (en) | 2001-07-23 |
| BR9911679A (en) | 2002-01-29 |
| HUP0103712A2 (en) | 2002-05-29 |
| HUP0103712A3 (en) | 2002-09-30 |
| CZ20004923A3 (en) | 2001-08-15 |
| AU4903999A (en) | 2000-01-24 |
| GB9814316D0 (en) | 1998-09-02 |
| IL140385A0 (en) | 2002-02-10 |
| NO20006547L (en) | 2001-02-12 |
| EA200100098A1 (en) | 2001-08-27 |
| PL345365A1 (en) | 2001-12-17 |
| JP2002519421A (en) | 2002-07-02 |
| CN1314906A (en) | 2001-09-26 |
| AU2002100370A4 (en) | 2002-06-06 |
| SK20242000A3 (en) | 2001-07-10 |
| ID27766A (en) | 2001-04-26 |
| WO2000001692A1 (en) | 2000-01-13 |
| EP1091958A1 (en) | 2001-04-18 |
| CA2336470A1 (en) | 2000-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2158778A1 (en) | Paroxetine methanesulfonate | |
| BR0016543A (en) | New piperidine and piperazine derivatives | |
| MY122391A (en) | Piperazine derivatives as 5-ht1b antagonists | |
| HUP0204515A3 (en) | 4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| SE9704546D0 (en) | Novel compounds | |
| BG64475B1 (en) | Ziprasidone salts | |
| MY125978A (en) | Admantane derivatives | |
| HUP0203320A3 (en) | Indolylpiperidine derivatives and their use as antihistaminic and antiallergic agents, process for their preparation, pharmaceutical compositions containing them | |
| SE9802208D0 (en) | Novel compounds | |
| AP2000002017A0 (en) | Salts of paroxetine. | |
| IL157540A0 (en) | N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof | |
| ZA966163B (en) | Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives. | |
| IL180579A0 (en) | Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them | |
| HUP0200133A3 (en) | Piperidine and piperazine derivatives as inhibitors of the abetha fibril formation, process for their preparation and pharmaceutical compositions containing them | |
| SE9802209D0 (en) | Novel compounds | |
| JO2199B1 (en) | Substituted pyrroles | |
| AU9270598A (en) | Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates | |
| HUP9800707A2 (en) | Phenoxymethyl piperidine derivatives, process for producing them, and pharmaceutical compositions containing them | |
| HUP0200412A3 (en) | New morpholinobenzamide salts, process for their preparation and pharmaceutical compositions containing them and their use | |
| HUP0203161A3 (en) | Benzamidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use | |
| AU5685300A (en) | Solid preparations containing paroxetine | |
| SE9803107D0 (en) | Novel Compunds | |
| EP1221945A4 (en) | Methods, pharmaceutical and therapeutic compositions for administering adenosine | |
| HUP0100661A3 (en) | Salts of paroxetine, process for their preparation and medicaments containing the compounds | |
| DK1165596T3 (en) | 14,15-alpha-methylene-equilenin derivatives, process for their preparation and drugs containing them |